M
Masunori Matsuzaki
Researcher at Yamaguchi University
Publications - 522
Citations - 21743
Masunori Matsuzaki is an academic researcher from Yamaguchi University. The author has contributed to research in topics: Heart failure & Ryanodine receptor. The author has an hindex of 75, co-authored 514 publications receiving 20134 citations. Previous affiliations of Masunori Matsuzaki include Boston Biomedical Research Institute.
Papers
More filters
Journal ArticleDOI
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
Mitsuhiro Yokoyama,Hideki Origasa,Masunori Matsuzaki,Yuji Matsuzawa,Yasushi Saito,Yuichi Ishikawa,Shinichi Oikawa,Jun Sasaki,Hitoshi Hishida,Hiroshige Itakura,Toru Kita,Akira Kitabatake,Noriaki Nakaya,Toshiie Sakata,Kazuyuki Shimada,Kunio Shirato +15 more
TL;DR: Testing the hypothesis that long-term use of eicosapentaenoic acid (EPA) is effective for prevention of major coronary events in hypercholesterolaemic patients in Japan who consume a large amount of fish found it to be a promising treatment.
Journal ArticleDOI
Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase
Koichi Yoshimura,Hiroki Aoki,Yasuhiro Ikeda,Kozo Fujii,Norio Akiyama,Akira Furutani,Yoshinobu Hoshii,Nobuyuki Tanaka,Romeo Ricci,Tokuhiro Ishihara,Kensuke Esato,Kimikazu Hamano,Masunori Matsuzaki +12 more
TL;DR: It is shown that JNK programs a gene expression pattern in different cell types that cooperatively enhances the degradation of the extracellular matrix while suppressing biosynthetic enzymes of the Extracellular Matrix.
Journal ArticleDOI
Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results.
Kimikazu Hamano,Masahiko Nishida,Ken Hirata,Akihito Mikamo,Tao-Sheng Li,Masahiko Harada,Toshiro Miura,Masunori Matsuzaki,Kensuke Esato +8 more
TL;DR: This new therapy appears to be safe and could provide a treatment option for patients with otherwise untreatable ischemic heart disease.
Journal ArticleDOI
Direct Activation of Mitochondrial Apoptosis Machinery by c-Jun N-terminal Kinase in Adult Cardiac Myocytes
Hiroki Aoki,Hiroki Aoki,Peter M. Kang,James Hampe,Koichi Yoshimura,Takafumi Noma,Masunori Matsuzaki,Seigo Izumo +7 more
TL;DR: Findings indicate that the JNK pathway is a direct activator of mitochondrial death machinery without other cellular components and provide a molecular linkage from oxidative stress to the mitochondrial apoptosis machinery.
Journal ArticleDOI
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
Yasushi Saito,Mitsuhiro Yokoyama,Hideki Origasa,Masunori Matsuzaki,Yuji Matsuzawa,Yuichi Ishikawa,Shinichi Oikawa,Jun Sasaki,Hitoshi Hishida,Hiroshige Itakura,Toru Kita,Akira Kitabatake,Noriaki Nakaya,Toshiie Sakata,Kazuyuki Shimada,Kunio Shirato +15 more
TL;DR: EPA was effective in reducing the incidence of CAD events for patients with this dyslipidemic pattern, suggesting that EPA may be especially beneficial in patients who with abnormal TG and HDL-C levels.